CTNNA3
protein-codingcatenin alpha 3, the group of Alpha catenins|MicroRNA protein coding host genes
Gene summary
This gene encodes a protein that belongs to the vinculin/alpha-catenin family. The encoded protein plays a role in cell-cell adhesion in muscle cells. Mutations in this gene are associated with arrhythmogenic right ventricular dysplasia, familial 13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~1,851.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0016587
Submitter: G2P
Inheritance Pattern: Unknown
Disease ID:MONDO:0005453
Submitter: ClinGen
*CTNNA3* was first reported in relation to congenital heart disease in 2013 (Symou et al., PMID:23481551). Five probands with multi-gene CNVs (4 gross deletions, 1 duplication) at the 10q21.3 location have been reported in four publications (PMIDs: 23481551, 24297458, 28378413, 28472932). Although this gene-disease relationship is supported by a protein interaction study (PMID: 15302915), no reports have directly implicated the gene in humans. In summary, the evidence supporting the relationship between *CTNNA3* and congenital heart disease has been disputed and no valid evidence remains to support the claim. More evidence is needed to either support or entirely refute the role *CTNNA3* plays in this disease. This gene-disease pair was originally evaluated by the ClinGen Congenital Heart Disease GCEP on October 17th, 2023 (SOP Version 9). It was reevaluated on August 10th, 2026 (SOP Version 12). As a result of this reevaluation, no new evidence was reviewed and the classification did not change.
Inheritance Pattern: AD
Disease ID:MONDO:0016587
Submitter: ClinGen
CTNNA3: Arrythmogenic Right Ventricular Cardiomyopathy Mode of Inheritance: Autosomal dominant inheritance (HP:0000006) HGNC: 2511 MONDO:0016587 Expert Panel: Arrythmogenic Right Ventricular Cardiomyopathy Three papers were reviewed related to CTNNA3 and ARVD (23136403, 21254927, 224213630). In one paper the CTNNA3 gene was analyzed in 76 ARVD probands that were negative for PKP2, DSP, DSG2, DSC2, and JUP. In one of the probands the heterozygous NM_013266.3(CTNNA3):c.281T>A p.(Val94Asp) variant was found. This variant was not observed in 245296 reference alleles from gnomAD and was not present in both healthy parents and brother suggesting that the variant occurred de novo. Unfortunately no information was given about paternity testing or family history for ARVD. Another proband showed the heterozygous variant NM_013266.3(CTNNA3):c.2296_2298del p.(Leu766del). This variant was not found in 30971 reference alleles from gnomAD but was inherited from her father that only showed a mild right ventricular dilation. Her ant inherited the variant as well but she was asymptomatic. Yeast two-hybrid studies with both variants showed some aberrations (23136403). In another paper a missense variant was found in one of 55 Danish ARVD patients. The variant was found 37 times in 276338 (1 times homozygous) reference alleles in gnomAD making it less likely as a causal variant. In addition the proband did carry a missense variant of unknown significance in DSP (21254927). Germline knockout of alphaT-catenin encoded by ctnna3 in the mouse alters PKP2 distribution without affecting other junctional components of the areae Compositae. These mutant mice exhibit progressive dilated cardiomyopathy, gap junction remodelling, and increased sensitivity to ventricular arrhythmia following acute ischaemia, but not spontaneous ARVC (224213630). Total genetic evidence points calculated = 1.5; Total experimental evidence points calculated = 2; Total awarded points = 3.5; Final classification = Limited.
Inheritance Pattern: AD
Disease ID:MONDO:0000908
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0000908
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular
Intervention: Cardiovascular
Rationale: Individuals have been described as presenting with arrhthymias and echocardiographic findings including right ventricular dilatation and dyskinesia, and awareness can allow surveillance (eg, with echocardiogram, electrocardiogram) and preventive measures and early treatment (eg ,with ICD)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CTNNA3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_013266.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 266 | 2 | 273 | ||
| missense | 1 | 602 | 54 | 2 | 659 | |
| nonsense | 18 | 18 | ||||
| start loss | 2 | 2 | ||||
| frameshift | 2 | 26 | 28 | |||
| splice donor/acceptor (+/-2bp) | 1 | 15 | 2 | 18 | ||
| Total | 1 | 3 | 668 | 322 | 4 | 998 |
Highest pathogenic variant AF is 0.0000013681051
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_037398.2 | 17 | MANE Select | |
| Ensembl | ENSP00000389714.1 | 17 | MANE Select | |
| RefSeq | NP_001120856.1 | 17 | Standard | |
| RefSeq | NP_001278062.1 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Gastric cancer - Homo sapiens (human)
- Adherens junction - Homo sapiens (human)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human)
- Hippo signaling pathway - Homo sapiens (human)
- Bacterial invasion of epithelial cells - Homo sapiens (human)
Biological Process
- bundle of His cell-Purkinje myocyte adhesion involved in cell communication
- regulation of heart rate by cardiac conduction
- cell-cell adhesion
- regulation of ventricular cardiac muscle cell action potential
Molecular Function
- protein binding
- beta-catenin binding
- cadherin binding
- actin filament binding
Cellular Component
- cytoplasm
- cytoskeleton
- fascia adherens
- lamellipodium
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000433211
- Coding exons
- 17
- Length
- 1783652
- Individuals with no LoFs
- 125595
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 153
- Defined
- 125748
- p
- 0.000609
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.11 | 565 | 495 | 1.14 | 0.0000263 | 5884 |
| Missense (PolyPhen) | 13 | 26.369 | 0.49301 | 324 | ||
| Synonymous | -0.516 | 184 | 175 | 1.05 | 0.00000941 | 1703 |
| Loss of Function | 2.34 | 26 | 42.4 | 0.613 | 0.00000225 | 535 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.00055 | 0.00055 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00066 | 0.00065 | rare |
| Finnish | 0.0011 | 0.0011 | notable |
| European (Non-Finnish) | 0.00048 | 0.00047 | rare |
| South Asian | 0.0012 | 0.0010 | notable |
| Other | 0.00098 | 0.00098 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May be involved in formation of stretch-resistant cell- cell adhesion complexes. {ECO:0000303|PubMed:11590244}.;
Recessive Scores
- pRec
- 0.186
Intolerance Scores
- LoFtool
- 0.863
- RVIS EVS
- -1.01
- RVIS percentile EVS
- 8.2
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.619
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |